Deep Tech Startups

Gearbox Biosciences develops Pop-Out-Plasmid (POP) technology, an E. coli platform that produces plasmid DNA and recombinant proteins without antibiotic selection markers or chemical inducers like IPTG, while decoupling growth from production. Its products serve biopharma partners in gene therapy, cell therapy, and vaccine manufacturing, and the technology is available for licensing.

1 investor

Gedy Trass develops engineering tools and provides consulting for mechanical design, specializing in static and dynamic analysis, FE linear and non-linear simulations, rotordynamics, gear/NVH analysis, and test bench design. It serves clients needing structural dynamics and experimental analysis in mechanical engineering.

1 investor

Geegah develops ultrasonic imaging devices that use gigahertz-frequency piezoelectric transducers to capture high-resolution surface images of solid and liquid samples. The company serves research, materials science, and industrial inspection applications with hardware that integrates transmitter and receiver transducers on a single chip.

1 investor

Gelest manufactures specialty silanes, silicones, metal-organic compounds, and acrylates for advanced technology markets including coatings, adhesives, medical devices, life sciences, and personal care. The company operates manufacturing facilities, R&D labs, and logistics centers with capabilities spanning custom synthesis, surface modification, and analytical services.

1 investor

GemaTEG develops thermal management solutions for high-performance computing systems, focusing on improving efficiency and reducing energy consumption in AI and HPC environments. The company serves cloud and computing infrastructure operators seeking to balance performance with environmental responsibility.

1 investor

Generation Alpha builds AI-driven tooling for designing analog semiconductor circuits, positioning its technology for chip and silicon design work. Its offerings target semiconductor and electronic design automation engineers.

1 investor

Gene BioSystems manufactures ready-to-use qPCR reagent kits for quantitative PCR analysis across major real-time PCR systems. The products are designed for research laboratories and diagnostic facilities requiring molecular biology testing reagents.

1 investor

GeneLancet develops proprietary LgRNA technology for precise gene editing, with applications in CRISPR polymerase-directed therapies targeting neurodegenerative diseases and cancers with unmet medical needs.

1 investor

GeneNeer develops advanced gene-editing platforms to accelerate the development of crop seeds with improved yield, growth, and nutritional value for the agricultural supply chain. The company uses proprietary methods offering superior efficiency, precision, speed and affordability compared to existing CRISPR and similar technologies.

1 investor

Generable develops statistical and computational models for drug development and healthcare decision-making, leveraging Bayesian methods and probabilistic modeling. The company serves pharmaceutical and biotech organizations in developing safer and more efficient therapeutic interventions.

1 investor

General Aeronautics develops unmanned aerial vehicle (drone) technologies, including a spray drone platform for precision agriculture and crop protection, and offers aircraft design and UAV development services for aircraft OEMs. It applies its aeronautical, AI, and agronomy expertise to address challenges in agriculture, healthcare, and drone design.

1 investor

Gila Labs manufactures a stereo head-mounted camera system with integrated IMU for collecting synchronized egocentric video and motion data at scale. The device is designed to capture natural human behavior for training robotics foundation models.

1 investor

General Oceans is a group of underwater technology businesses that design, manufacture and support subsea systems including ADCP and DVL instruments, sonar imaging, underwater robotics and ocean data collection. It serves customers in defense, ocean science and marine construction operating in demanding marine environments across more than 65 countries.

1 investor

General Radar develops radar and weapons systems technology for the defense and aerospace sectors. The company serves government and military customers requiring advanced sensor and missile defense capabilities.

1 investor

General Tensor is a vertically integrated business focused on decentralized AI within the Bittensor network, operating across subnet development, validation, and mining. It builds and acquires assets—such as its RoundTable21 validator and Project Rubicon, a bridge from Bittensor to Base—to produce and support decentralized AI infrastructure.

1 investor

General Orbit develops magnetic navigation systems and sensors that enable positioning and navigation in GPS-denied or noisy environments for critical infrastructure and autonomous platforms. The company simplifies the design and deployment of these systems to increase reliability and reduce dependence on traditional GPS.

1 investor

Generation Space is a space investment and management firm that appears to operate through Seraphim Space Manager LLP. The company manages investment vehicles and funds focused on the space sector.

1 investor

Genesys Aerosystems, part of Moog, provides avionics systems and integration for fixed-wing and rotary aircraft, including the OASIS open-architecture display software and the Genesys Avionics Suite. It serves military and defense, business, and general aviation customers, offering avionics modernization, certification, and pilot training services.

1 investor

Genetic Networks is a biotech company conducting discovery research on a conserved biological network to generate findings applicable across diseases, drugs, and therapeutic targets in medicine.

1 investor

Genetix Biotherapeutics develops gene addition therapies that use a patient's own cells to treat the underlying cause of rare diseases with a single dose, with a focus on hematology conditions such as sickle cell disease. The company has three FDA-approved one-time treatments for rare diseases.

1 investor

GENEWIZ provides sequencing, synthesis, and molecular biology services for research, clinical, and therapeutic applications, serving academic institutions, biotech companies, and pharmaceutical organizations.

1 investor

GenGenAI builds domain-specific generative AI that creates synthetic training data and annotations for vision AI models, addressing data scarcity for scenarios that are rare or costly to capture in the real world. It targets domains including autonomous driving, defense, surveillance, and home electronics.

1 investor

Genki Robotics develops humanoid robotic systems built on physical AI, combining intelligence, dexterity, and resilience for use in public safety, urban maintenance, and other mission-driven environments. The company aims to integrate intelligent humanoids into society to augment human capability.

1 investor

Genoa Instruments develops optical microscopy hardware and software, including PRISM, a Photon-Resolved Image Scanning Microscope built on SPAD array technology for quantitative fluorescence imaging. It targets researchers performing super-resolution and lifetime imaging studies on living biological samples, and is a spin-off of the Istituto Italiano di Tecnologia in Italy.

1 investor